Shanghai MicroPort MedBot (Group) Co., Ltd.
HKSE: 2252.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Chao He
- Employees
- 450
- Headquarters
- Shanghai, China
- IPO year
- 2021
- Market cap
- HK$29.7B
- Website
- https://www.medbotsurgical.com
Loading 2252…
Loading profile data…Frequently asked questions about 2252
What does Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK) do?
Shanghai Microport Medbot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China and Europe. It offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used...
Where does 2252.HK trade?
Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK) trades on the Hong Kong Stock Exchange.
What sector is 2252.HK in?
Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Shanghai MicroPort MedBot (Group) Co., Ltd.?
Chao He is the chief executive officer of Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK).
Where is Shanghai MicroPort MedBot (Group) Co., Ltd. headquartered?
Shanghai MicroPort MedBot (Group) Co., Ltd. is headquartered in China.
Does 2252.HK pay a dividend?
Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 2252.HK go public?
Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK) completed its initial public offering in 2021.